After a recent first-hand look, Russell McInnes shares some perspectives on India's burgeoning biotech industry. [ + ]

Producing products from human blood plasma is a lucrative business and the Chinese market provides a significant long-term opportunity, AVT Plasma's CEO tells Ruth Beran. [ + ]

Peter Beattie talks to Graeme O'Neill about his vision of the future for Queensland bioscience. [ + ]

State government policy has been vital in helping to shape the Australian biotechnology industry. Here, Cristy Burne takes us for a tour of Western Australia, the state that later this year will host the national biotech conference. [ + ]

There's no tyranny in distance for some globetrotting Australian biotechnology companies, writes Michael Vitale [ + ]

Opened by the Victorian premier earlier this month, the Bio21 Institute provides a structure in which research, business incubation and commercialisation are all conducted under one collaborative roof, Anne Fletcher reports. [ + ]

The nanotech sector in Australia is growing with potential. [ + ]

Is RNAi the real deal? Graeme O'Neill asked Australian scientist and global authority John Mattick. [ + ]

Keith Williams reflects on the long and winding road he has travelled as a player in the filed of protein science. [ + ]

An Adelaide pharmacist and student has developed software that could help slash drug side effects. The software is already helping research into the side effects of medications used to treat cancer and other diseases

Recently, some manufacturers of Australian wine have been criticised for deliberately and deceptively catering to the 'medal' mentality of many consumers

When Diana Hill went looking for significant new commercial opportunities in New Zealand's meat industry, she decided she'd better get down and dirty, so she spent a month in a meat processing plant asking where the hell the next billion dollar business was. [ + ]

Ruth Beran discovers how one of Australia's great bioentrepreneurs has moved from inspiring shareholders to inspiring a nation. [ + ]

Australian Biotechnology News journalist Ruth Beran asked Axon Instruments founder Alan Finkel if he had any advice for Australian companies with an eye on the world stage. Here is his reply. [ + ]

A young American genetist is embarking on a project which could solve many of the mysteries of human history, and give each of us a chance to find out about our our oldest ancestors. [ + ]